Vita Life Sciences director Peter Osborne increases stake in company

Peter Osborne, a director at Vita Life Sciences Limited, increased his direct interest in the company's ordinary shares on October 7, 2025. This on-market trade saw Osborne acquire an additional 2,000 ordinary shares at a price of A$2.43 per share.

Prior to this transaction, Osborne held 41,184 ordinary shares. Following the acquisition, his total direct holdings in Vita Life Sciences now stand at 43,184 ordinary shares. The previous notification of his interest was dated May 6, 2025.

The transaction occurred outside of a closed period, meaning no prior written clearance was required for the trade to proceed.